This site has just undergone scheduled maintenance in order to be moved to a new infrastructure. You shouldn’t experience any change, but do let us know (datacentre@scilifelab.se) if you think anything looks out of place.

Glioblastoma Cell Malignancy and Drug Sensitivity Are Affected by the Cell of Origin.

Jiang Y, Marinescu VD, Xie Y, Jarvius M, Maturi NP, Haglund C, Olofsson S, Lindberg N, Olofsson T, Leijonmarck C, Hesselager G, Alafuzoff I, Fryknäs M, Larsson R, Nelander S, Uhrbom L

Cell Rep 19 (5) 1080-1081 [2017-05-02; online 2017-05-04]

Drug Discovery and Development (DDD) [Service]

PubMed 28467901

DOI 10.1016/j.celrep.2017.04.053

Crossref 10.1016/j.celrep.2017.04.053

pii: S2211-1247(17)30564-8


Publications 9.5.1